You are here

A COMPUTER-BASED HIV MEDICATION ADHERENCE INTERVENTION

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44AI044558-02A1
Agency Tracking Number: AI044558
Amount: $0.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2002
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
WEST PORTAL SOFTWARE CORPORATION 332 PINE ST, STE 610
SAN FRANCISCO, CA 94104
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ROGER HOFMANN
 (415) 677-0320
 RHOFMANN@WESTPORTAL.COM
Business Contact
 ROGER HOFMANN
Phone: (415) 677-0320
Email: RHOFMANN@WESTPORTAL.COM
Research Institution
N/A
Abstract

Highly active antiretroviral therapy for HIV produces dramatic reductions in morbidity and mortality for many individuals who maintain a very high level of adherence to their medications. Between 20 and 33 percent of HIV-seropositive patients will miss at least one of their medication doses over a 1 to 3 day period. To improve patient adherence, we must accurately assess non-adherence and intervene to enhance adherence. Patient self-report is the most practical method for assessing adherence, but may produce unreliable and invalid results unless optimally performed. A computer-assisted, self-administered adherence program could improve HIV-seropositive patients' adherence behaviors by accurately and efficiently assessing their medication adherence, delivering an adherence intervention to patients, and producing adherence reports for providers. Patients could routinely complete the program with minimal use of valuable and costly medical staff time. By providing a neutral and seemingly private
interview, computer programs may increase patient disclosure of non-adherence. In Phase I, we successfully developed a computerized HIV medication assessment that identified serious patient medication errors and non-adherence. Phase II efforts will be directed toward simplifying the adherence assessment, developing the intervention component of the adherence program, and testing the complete program's efficacy in reducing regimen misunderstandings and enhancing patient adherence.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government